BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 12216079)

  • 1. Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP.
    Nakayama K; Kanzaki A; Ogawa K; Miyazaki K; Neamati N; Takebayashi Y
    Int J Cancer; 2002 Oct; 101(5):488-95. PubMed ID: 12216079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma.
    Kanzaki A; Toi M; Neamati N; Miyashita H; Oubu M; Nakayama K; Bando H; Ogawa K; Mutoh M; Mori S; Terada K; Sugiyama T; Fukumoto M; Takebayashi Y
    Jpn J Cancer Res; 2002 Jan; 93(1):70-7. PubMed ID: 11802810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy.
    Nakayama K; Kanzaki A; Terada K; Mutoh M; Ogawa K; Sugiyama T; Takenoshita S; Itoh K; Yaegashi N; Miyazaki K; Neamati N; Takebayashi Y
    Clin Cancer Res; 2004 Apr; 10(8):2804-11. PubMed ID: 15102688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
    Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
    Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin.
    Miyashita H; Nitta Y; Mori S; Kanzaki A; Nakayama K; Terada K; Sugiyama T; Kawamura H; Sato A; Morikawa H; Motegi K; Takebayashi Y
    Oral Oncol; 2003 Feb; 39(2):157-62. PubMed ID: 12509969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of copper-transporting P-type adenosine triphosphatase in human esophageal carcinoma.
    Higashimoto M; Kanzaki A; Shimakawa T; Konno S; Naritaka Y; Nitta Y; Mori S; Shirata S; Yoshida A; Terada K; Sugiyama T; Ogawa K; Takebayashi Y
    Int J Mol Med; 2003 Mar; 11(3):337-41. PubMed ID: 12579336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines.
    Nakayama K; Miyazaki K; Kanzaki A; Fukumoto M; Takebayashi Y
    Oncol Rep; 2001; 8(6):1285-7. PubMed ID: 11605050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.
    Nakagawa T; Inoue Y; Kodama H; Yamazaki H; Kawai K; Suemizu H; Masuda R; Iwazaki M; Yamada S; Ueyama Y; Inoue H; Nakamura M
    Oncol Rep; 2008 Aug; 20(2):265-70. PubMed ID: 18636185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
    Arts HJ; Katsaros D; de Vries EG; Massobrio M; Genta F; Danese S; Arisio R; Scheper RJ; Kool M; Scheffer GL; Willemse PH; van der Zee AG; Suurmeijer AJ
    Clin Cancer Res; 1999 Oct; 5(10):2798-805. PubMed ID: 10537344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival.
    Li J; Li ZN; Du YJ; Li XQ; Bao QL; Chen P
    Clin Lung Cancer; 2009 Nov; 10(6):414-21. PubMed ID: 19900859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
    Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
    Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinomas.
    Kanzaki A; Nakayama K; Miyashita H; Shirata S; Nitta Y; Oubu M; Higashimoto M; Mutoh M; Mori S; Konno S; Ogawa K; Toi M; Takebayashi Y
    Anticancer Res; 2003; 23(2C):1913-5. PubMed ID: 12820478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of multidrug resistance-related transporters in human breast carcinoma.
    Kanzaki A; Toi M; Nakayama K; Bando H; Mutoh M; Uchida T; Fukumoto M; Takebayashi Y
    Jpn J Cancer Res; 2001 Apr; 92(4):452-8. PubMed ID: 11346468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
    Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK
    Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte.
    Takebayashi Y; Nakayama K; Fujioka T; Kanzaki A; Mutho M; Uchida T; Miyazaki K; Ito M; Fukumoto M
    Int J Mol Med; 2001 Apr; 7(4):397-400. PubMed ID: 11254880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP7B antisense oligodeoxynucleotides increase the cisplatin sensitivity of human ovarian cancer cell line SKOV3ipl.
    Xu W; Cai B; Chen JL; Li LX; Zhang JR; Sun YY; Wan XP
    Int J Gynecol Cancer; 2008; 18(4):718-22. PubMed ID: 17944925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is ATP7B a predictive marker in patients with ovarian carcinoma treated with platinum-taxane combination chemotherapy?
    Katagiri H; Nakayama K; Rahman MT; Rahman M; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Nakayama S; Otsuki Y; Miyazaki K
    Int J Gynecol Cancer; 2013 Jan; 23(1):60-4. PubMed ID: 23221602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
    Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.
    Kalayda GV; Wagner CH; Buss I; Reedijk J; Jaehde U
    BMC Cancer; 2008 Jun; 8():175. PubMed ID: 18565219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) in human hepatocellular carcinoma.
    Sugeno H; Takebayashi Y; Higashimoto M; Ogura Y; Shibukawa G; Kanzaki A; Terada K; Sugiyama T; Watanabe K; Katoh R; Nitta Y; Fukushima T; Koyama Y; Inoue N; Sekikawa K; Ogawa K; Sato Y; Takenoshita S
    Anticancer Res; 2004; 24(2C):1045-8. PubMed ID: 15154620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.